Pentasa

Pentasa is a brand name of mesalamine, approved by the FDA in the following formulation(s):

PENTASA (mesalamine - capsule, extended release; oral)

• 
  Manufacturer: SHIRE
  
  Approval date: May 10, 1993
  
  Strength(s): 250MG
  


• 
  Manufacturer: SHIRE
  
  Approval date: July 8, 2004
  
  Strength(s): 500MG ^[RLD]

Has a generic version of Pentasa been approved?

No. There is currently no therapeutically equivalent version of Pentasa available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pentasa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Pentasa.

See also...

• Pentasa Consumer Information (Drugs.com)
• Pentasa Controlled-Release Capsules Consumer Information (Wolters Kluwer)
• Pentasa Consumer Information (Cerner Multum)
• Pentasa Advanced Consumer Information (Micromedex)
• Pentasa Rectal Advanced Consumer Information (Micromedex)
• Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Mesalamine Enema Consumer Information (Wolters Kluwer)
• Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Suppositories Consumer Information (Wolters Kluwer)
• Mesalamine Consumer Information (Cerner Multum)
• Mesalamine rectal Consumer Information (Cerner Multum)
• Mesalamine Advanced Consumer Information (Micromedex)
• Mesalamine Rectal Advanced Consumer Information (Micromedex)
• SfRowasa Advanced Consumer Information (Micromedex)
• Mesalamine AHFS DI Monographs (ASHP)